Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure.

Abstract

The tumor suppressor, PTEN, is one of the most commonly mutated genes in cancer. Recently, PTEN has been shown to localize in the nucleus and is required to maintain genomic stability. Here, we show that nuclear PTEN, independent of its phosphatase activity, is essential for maintaining heterochromatin structure. Depletion of PTEN leads to loss of heterochromatic foci, decreased chromatin compaction, overexpression of heterochromatic genes, and reduced protein stability of heterochromatin protein 1 α. We found that the C-terminus of PTEN is required to maintain heterochromatin structure. Additionally, cancer-associated PTEN mutants lost their tumor-suppressor function when their heterochromatin structure was compromised. We propose that this novel role of PTEN accounts for its function in guarding genomic stability and suppressing tumor development.

• Authors: Lili Gong, Jeane M Govan, Elizabeth B Evans, Hui Dai, Edward Wang, Szu-Wei Lee, Hui-Kuan Lin, Alexander J Lazar, Gordon B Mills, Shiaw-Yih Lin
• Journal: Cell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 14 Issue 14 Pg. 2323-32 ( 2015) ISSN: 1551-4005 [Electronic] United States
• PMID: 25946202 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• CBX5 protein, human
• Chromones
• Chromosomal Proteins, Non-Histone
• Heterochromatin
• Morpholines
• Phosphoinositide-3 Kinase Inhibitors
• RNA, Small Interfering
• Chromobox Protein Homolog 5
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
• PTEN Phosphohydrolase
• PTEN protein, human

Topics

• Animals
• Cell Line
• Cell Nucleus (metabolism)
• Cell Survival (drug effects)
• Chromobox Protein Homolog 5
• Chromones (pharmacology)
• Chromosomal Proteins, Non-Histone (metabolism)
• Heterochromatin (chemistry, metabolism)
• Humans
• Immunoprecipitation
• Mice
• Morpholines (pharmacology)
• PTEN Phosphohydrolase (antagonists & inhibitors, genetics, metabolism)
• Phosphatidylinositol 3-Kinases (metabolism)
• Phosphoinositide-3 Kinase Inhibitors
• Protein Structure, Tertiary
• RNA Interference
• RNA, Small Interfering (metabolism)